Triple

T20300929
Position Surface form Disambiguated ID Type / Status
Subject Astra AB E505476 entity
Predicate notableProduct P1448 FINISHED
Object Losec
Losec is a widely used proton pump inhibitor medication (omeprazole) for treating acid-related stomach and esophageal conditions such as ulcers and gastroesophageal reflux disease (GERD).
E1423940 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Losec | Statement: [Astra AB, notableProduct, Losec]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Losec
Context triple: [Astra AB, notableProduct, Losec]
  • A. Pepcid
    Pepcid is a widely used over-the-counter and prescription heartburn and acid reflux medication whose brand is owned by Kenvue.
  • B. Gaviscon
    Gaviscon is an over-the-counter antacid and reflux relief medication commonly used to treat heartburn and indigestion.
  • C. Panazol
    Panazol is a suburban commune in west-central France, located just east of the city of Limoges in the Nouvelle-Aquitaine region.
  • D. Altabix
    Altabix is a residential neighborhood in the city of Elche, Spain, known for its local sports facilities and community-focused urban environment.
  • E. Andexxa
    Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Losec
Triple: [Astra AB, notableProduct, Losec]
Generated description
Losec is a widely used proton pump inhibitor medication (omeprazole) for treating acid-related stomach and esophageal conditions such as ulcers and gastroesophageal reflux disease (GERD).
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Losec
Target entity description: Losec is a widely used proton pump inhibitor medication (omeprazole) for treating acid-related stomach and esophageal conditions such as ulcers and gastroesophageal reflux disease (GERD).
  • A. Pepcid
    Pepcid is a widely used over-the-counter and prescription heartburn and acid reflux medication whose brand is owned by Kenvue.
  • B. Gaviscon
    Gaviscon is an over-the-counter antacid and reflux relief medication commonly used to treat heartburn and indigestion.
  • C. Panazol
    Panazol is a suburban commune in west-central France, located just east of the city of Limoges in the Nouvelle-Aquitaine region.
  • D. Altabix
    Altabix is a residential neighborhood in the city of Elche, Spain, known for its local sports facilities and community-focused urban environment.
  • E. Andexxa
    Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b4b8ab648190906e18538c250148 completed April 16, 2026, 10:06 a.m.
NER Named-entity recognition batch_69e6770c700c81909da247cef0d0f1eb completed April 20, 2026, 6:57 p.m.
NED1 Entity disambiguation (via context triple) batch_6a08611762e481909ee2f41434c86aa5 completed May 16, 2026, 12:20 p.m.
NEDg Description generation batch_6a0863506f4481909c106c49f6b71191 completed May 16, 2026, 12:30 p.m.
NED2 Entity disambiguation (via description) batch_6a0863f4bb788190b6ef1fe57279badb completed May 16, 2026, 12:32 p.m.
Created at: April 16, 2026, 11:16 a.m.